Xtant Medical Holdings (XTNT) Net Margin (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Net Margin data on file, last reported at 3.93% in Q3 2025.

• On a quarterly basis, Net Margin rose 2192.0% year-over-year to 3.93% in Q3 2025; TTM through Sep 2025 was 1.32%, a 1843.0% increase from a year earlier, with the FY2024 full-year figure at 14.03%, down 1267.0% from the prior year.
• Net Margin for Q3 2025 stood at 3.93%, down from 10.03% in the prior quarter.
• Over the last five years, Net Margin for XTNT reached as high as 36.9% in Q3 2023 and fell as low as 22.07% in Q4 2023.
• Historically, Net Margin has averaged 7.18% across 5 years, with a median of 11.19% in 2022.
• Across the five-year window, Net Margin jumped 5317 bps in 2023 and slumped 5488 bps in 2024, its largest moves.
• Year by year, Net Margin stood at 8.99% in 2021, then slumped by 61 bps to 14.47% in 2022, then sank by 53 bps to 22.07% in 2023, then jumped by 54 bps to 10.04% in 2024, then surged by 139 bps to 3.93% in 2025.
• Per Business Quant data, the three most recent Net Margin figures were 3.93% in Q3 2025, 10.03% in Q2 2025, and 0.18% in Q1 2025.